Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia

Pediatric Cardiology

Volumn 36, Issue 6, 2015, Pages 1255-1260

  Trottier Boucher, M N ^a   Lapointe, A ^a   Malo, J ^a   Fournier, A ^a   Raboisson, M J ^a   Martin, B ^a   Moussa, A ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bronchopulmonary dysplasia; Infants; Pulmonary hypertension; Sildenafil

Indexed keywords

SILDENAFIL; OXYGEN; PHOSPHODIESTERASE V INHIBITOR;

ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPOTENSION; INFANT; LUNG DYSPLASIA; MALE; MEDICAL RECORD; NEWBORN INTENSIVE CARE; OXYGEN CONSUMPTION; PREMATURITY; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; TRICUSPID VALVE REGURGITATION; BREATHING RATE; CHEMICALLY INDUCED; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; ECHOGRAPHY; EVALUATION STUDY; HYPERTENSION, PULMONARY; METABOLISM; NEWBORN; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY;

BRONCHOPULMONARY DYSPLASIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; HYPOTENSION; INFANT; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MALE; OXYGEN; PHOSPHODIESTERASE 5 INHIBITORS; RESPIRATORY RATE; RETROSPECTIVE STUDIES; SILDENAFIL CITRATE; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY;

EID: 84937633245     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-015-1154-0     Document Type: Article

References (24)

1. Ahsman MJ, Witjes BC, Wildschut ED, Sluiter I, Vulto AG, Tibboel D, Mathot RA (2010) Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed 95(2):F109–F114. doi:10.1136/adc.2009.168336
2. An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, Kim HS, Choi JH, Noh CI, Yun YS (2010) Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40(3):131–136. doi:10.4070/kcj.2010.40.3.131
3. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55–S66. doi:10.1016/j.jacc.2009.04.011
4. Baquero H, Soliz A, Neira F, Venegas ME, Sola A (2006) Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117(4):1077–1083. doi:10.1542/peds.2005-0523
5. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K (2005) Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia. Pediatrics 116(6):1353–1360. doi:10.1542/peds.2005-0249
6. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196(2):147. doi:10.1016/j.ajog.2006.09.014 e141–148
7. Fang AY, Guy KJ, Konig K (2013) The effect of sildenafil on retinopathy of prematurity in very preterm infants. J Perinatol 33(3):218–221. doi:10.1038/jp.2012.84
8. Herrera TR, Concha GP, Holberto CJ, Loera GR, Rodríguez BI (2006) Oral sildenafil as an alternative treatment in the persistent pulmonary hypertension in newborns. Rev Mex Pediatr 74(4):159–163
9. Kehat R, Bonsall DJ, North R, Connors B (2010) Ocular findings of oral sildenafil use in term and near-term neonates. J AAPOS 14(2):159–162. doi:10.1016/j.jaapos.2009.12.161
10. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP (2007) Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120(6):1260–1269. doi:10.1542/peds.2007-0971
11. Khorana M, Yookaseam T, Layangool T, Kanjanapattanakul W, Paradeevisut H (2011) Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health. J Med Assoc Thai 94(Suppl 3):64–73
12. Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH (2012) Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 101(1):40–46. doi:10.1159/000327891
13. Limjoco J, Paquette L, Ramanathan R, Seri I, Friedlich P (2013) Changes in mean arterial blood pressure during sildenafil use in neonates with meconium aspiration syndrome or sepsis. Am J Ther. doi:10.1097/MJT.0b013e31826fc4ec
14. Marsh CS, Marden B, Newsom R (2004) Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 88(2):306–307
15. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH (2008) Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 121(2):317–325. doi:10.1542/peds.2007-1583
16. Mourani PM, Ivy DD, Rosenberg AA, Fagan TE, Abman SH (2008) Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. J Pediatr 152(2):291–293. doi:10.1016/j.jpeds.2007.11.006
17. Mourani PM, Sontag MK, Ivy DD, Abman SH (2009) Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 154(3):379–384. doi:10.1016/j.jpeds.2008.09.021 e371–372
18. Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH (2015) Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 191(1):87–95. doi:10.1164/rccm.201409-1594OC
19. Nyp M, Sandritter T, Poppinga N, Simon C, Truog WE (2012) Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? J Perinatol Off J Calif Perinat Assoc 32(1):64–69. doi:10.1038/jp.2011.131
20. Patel N, Mills JF, Cheung MM (2009) Assessment of right ventricular function using tissue Doppler imaging in infants with pulmonary hypertension. Neonatology 96(3):193–199. discussion 200-192. doi:10.1159/000215585
21. Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA (2011) Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31(10):635–640. doi:10.1038/jp.2010.213
22. Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M, Wessel DL (2009) Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 155(6):841–847. doi:10.1016/j.jpeds.2009.06.012 e841
23. Stenmark KR, Abman SH (2005) Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 67:623–661. doi:10.1146/annurev.physiol.67.040403.102229
24. Vargas-Origel A, Gomez-Rodriguez G, Aldana-Valenzuela C, Vela-Huerta MM, Alarcon-Santos SB, Amador-Licona N (2010) The use of sildenafil in persistent pulmonary hypertension of the newborn. Am J Perinatol 27(3):225–230. doi:10.1055/s-0029-1239496